Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Maxim Group Downgrades Kiora Pharmaceuticals to Hold

Maxim Group Downgrades Kiora Pharmaceuticals to Hold

Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.

August 15, 2022

1 minute read

Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.

Weak iPhone Demand Could Lead To Apple’s Largest Q3 Revenue Drop Since 2016

August 2, 4:46 AM

iPhone sales are slowing down in the US and South America and are flat in China as people wait for the iPhone 15 series.

July 7, 5:57 AM

Google's planned switch to its first fully-custom designed Tensor chipset with TSMC has been pushed back to 2025.

December 6, 2:03 PM

GLJ Research analyst Gordon Johnson downgraded First Solar Inc (NASDAQ:FSLR) from Buy to Sell and lowered the price target from $138.4 to…

December 29, 1:23 PM

Bitcoin mining companies, Marathon Digital Holdings, Inc. (NASDAQ: MARA) and Riot Platforms, Inc. (NASDAQ: RIOT), shares are trading lower Friday.